BR0007428A - Composições com estabilidade aprimorada - Google Patents

Composições com estabilidade aprimorada

Info

Publication number
BR0007428A
BR0007428A BR0007428-4A BR0007428A BR0007428A BR 0007428 A BR0007428 A BR 0007428A BR 0007428 A BR0007428 A BR 0007428A BR 0007428 A BR0007428 A BR 0007428A
Authority
BR
Brazil
Prior art keywords
compositions
liquid
improved stability
pharmaceutical active
atomizers
Prior art date
Application number
BR0007428-4A
Other languages
English (en)
Inventor
Douglas Joseph Dobrozsi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR0007428A publication Critical patent/BR0007428A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES COM ESTABILIDADE APRIMORADA". A presente invenção pertence a composições com veiculação dos princípio ativo farmacêuticos aprimorada. Estas composições compreendem princípio ativo farmacêuticos em um solvente. Estas composições podem tomar a forma de elixires líquidos postos na boca e eventualmente ingeridos ou podem ser veiculadas através de pastilhas preenchidas com líquido, dispositivos de dosagem com a medida de líquido, atomizadores e cápsulas comestíveis que liberam líquido.
BR0007428-4A 1999-01-11 2000-01-10 Composições com estabilidade aprimorada BR0007428A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11537899P 1999-01-11 1999-01-11
US15653999P 1999-09-29 1999-09-29
PCT/US2000/000574 WO2000041692A2 (en) 1999-01-11 2000-01-10 Compositions having improved stability

Publications (1)

Publication Number Publication Date
BR0007428A true BR0007428A (pt) 2002-10-15

Family

ID=26813132

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007428-4A BR0007428A (pt) 1999-01-11 2000-01-10 Composições com estabilidade aprimorada

Country Status (16)

Country Link
US (1) US20020086878A1 (pt)
EP (1) EP1143973A2 (pt)
JP (1) JP2002534462A (pt)
KR (1) KR20010093256A (pt)
CN (1) CN1346270A (pt)
AU (1) AU3344900A (pt)
BR (1) BR0007428A (pt)
CA (1) CA2360358A1 (pt)
CO (1) CO5430216A1 (pt)
CZ (1) CZ20012493A3 (pt)
HU (1) HUP0105279A3 (pt)
ID (1) ID30508A (pt)
NO (1) NO20013440L (pt)
PE (1) PE20001397A1 (pt)
TR (1) TR200101929T2 (pt)
WO (1) WO2000041692A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3984225B2 (ja) 2002-02-08 2007-10-03 ザ プロクター アンド ギャンブル カンパニー 子供用安全袋
US20040028622A1 (en) * 2002-08-12 2004-02-12 Michael Gurin Multifunctional flavor systems and method of use
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
US20070048424A1 (en) * 2005-09-01 2007-03-01 Moza Ashok K Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer
US20070059417A1 (en) * 2005-09-15 2007-03-15 Moza Ashok K Cooling agents as flavor and saltiness enhancers
FR2906140B1 (fr) * 2006-09-22 2008-12-05 Philippe Perovitch Forme galenique pour l'administration par voie trans-muqueuse de principes actifs
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
AU2008335809A1 (en) * 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
WO2018183203A1 (en) * 2017-03-27 2018-10-04 DXM Pharmaceutical, Inc. Packaged multi-dose liquid drug formulation
US11234897B2 (en) 2017-03-27 2022-02-01 DXM Pharmaceutical, Inc. Packaged multi-dose liquid dextromethorphan hydrobromide formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100898A (en) * 1990-01-25 1992-03-31 Richardson-Vicks Inc. Antitussive liquid compositions containing dyclonine
CN1138827A (zh) * 1994-01-24 1996-12-25 普罗克特和甘保尔公司 使难溶药物活性物增溶的方法
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids

Also Published As

Publication number Publication date
PE20001397A1 (es) 2000-12-21
WO2000041692A3 (en) 2000-11-30
NO20013440L (no) 2001-09-11
HUP0105279A2 (hu) 2002-05-29
KR20010093256A (ko) 2001-10-27
TR200101929T2 (tr) 2001-12-21
AU3344900A (en) 2000-08-01
CA2360358A1 (en) 2000-07-20
US20020086878A1 (en) 2002-07-04
WO2000041692A2 (en) 2000-07-20
CZ20012493A3 (cs) 2001-11-14
HUP0105279A3 (en) 2003-05-28
CO5430216A1 (es) 2004-06-01
NO20013440D0 (no) 2001-07-11
CN1346270A (zh) 2002-04-24
JP2002534462A (ja) 2002-10-15
EP1143973A2 (en) 2001-10-17
ID30508A (id) 2001-12-13

Similar Documents

Publication Publication Date Title
BR0007445A (pt) Composições tendo fornecimento aperfeiçoado de ingredientes ativos
BR0007428A (pt) Composições com estabilidade aprimorada
BR0014441A (pt) Composições que apresentam estabilidade aperfeiçoada
ES2193726T3 (es) Formulaciones de aerosol medicinales.
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
AR028299A1 (es) Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
BR0015188A (pt) Composições farmacêuticas
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
BR0012869A (pt) Forma de dosagem farmacêutica de componentes múltiplos
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
ATE200025T1 (de) Flüssige arzneizubereitungen enthaltend schilddrüsenhormone
BRPI0518266B8 (pt) medicamento oral de liberação modificada de pelo menos um princípio ativo sob a forma multimicrocapsular
NO20030897D0 (no) Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer
BR0211198A (pt) Composições farmacêuticas e seu uso
BR0007473A (pt) Composições tendo estabilidade melhorada
AR013739A1 (es) Composiciones de agentes reductores de lipidos
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
RS50241B (sr) Mikrogranule nerastvorljive u želudačnim sokovima, postupak za njihovo dobijanje i farmaceutski preparati
DE59914183D1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
BRPI9914031B8 (pt) partículas micronizadas de sulfometato de sódio colistina, composição, forma de dosagem farmacêutica e cápsula compreendendo as mesmas e processo para a preparação da referida composição.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.